Chatzikonstantinou, Thomas http://orcid.org/0000-0003-4105-1253
Agathangelidis, Andreas
Chatzidimitriou, Anastasia
Tresoldi, Cristina http://orcid.org/0000-0001-7711-5621
Davis, Zadie http://orcid.org/0000-0001-6959-4853
Giudicelli, Véronique http://orcid.org/0000-0002-2258-468X
Kossida, Sofia http://orcid.org/0000-0003-2482-0022
Belessi, Chrysoula
Rosenquist, Richard http://orcid.org/0000-0002-0211-8788
Ghia, Paolo http://orcid.org/0000-0003-3750-7342
Langerak, Anton W. http://orcid.org/0000-0002-2078-3220
Davi, Frédéric
Stamatopoulos, Kostas
,
Article History
Received: 21 December 2023
Revised: 17 January 2024
Accepted: 19 January 2024
First Online: 16 February 2024
Competing interests
: TC received honoraria from AbbVie, RR has received honoraria from AbbVie, AstraZeneca, Janssen, Illumina, and Roche. PG: received honoraria from AbbVie, AstraZeneca, BeiGene, BMS, Galapagos, Janssen, Loxo@LillyOncology, MSD, Roche; research funds from AbbVie, AstraZeneca, BMS; Janssen, AWL has received research support from Janssen, Gilead and Roche, FD has received honoraria from Janssen and Gilead, KS received honoraria from Janssen, Lilly, AstraZeneca; and research support from Janssen, Abbvie, AstraZeneca.